Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international clinical ...
The high rate of allergic reactions and other intolerable side effects of oral immunotherapy in the NIH-funded trial ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Academically, socially, and institutionally, America has not yet recovered from COVID-19 on the fifth anniversary of ...
M.D., M.P.H., director of NIH's National Institute of Allergy and Infectious Diseases (NIAID), the study's funder and ...
Harms of race-specific lung function calculations extend to asthma and treatment, particularly in Black children.
Food allergy, intolerance, and sensitivity generally differ based on whether or not IgE, a protein the body can make against ...